lumiracoxib

Known as: 2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid, 2-(2-((2-chloro-6-fluoro-phenyl)amino)-5-methyl-phenyl)acetic acid, Lumiracoxibum 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2018
010203020022018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Lumiracoxib is a selective cyclooxygenase-2 inhibitor developed for the symptomatic treatment of osteoarthritis and acute pain… (More)
  • figure 1
  • table 2
  • figure 2
Is this relevant?
2008
2008
BACKGROUND & AIMS The selective cyclooxygenase-2 inhibitor lumiracoxib has been shown to reduce endoscopically detected ulcers… (More)
Is this relevant?
2007
2007
BACKGROUND Evidence suggests that both selective cyclooxygenase (COX)-2 inhibitors and non-selective non-steroidal anti… (More)
Is this relevant?
2007
2007
BACKGROUND AND PURPOSE Non-steroidal anti-inflammatory drugs (NSAIDs) are analgesic and anti-inflammatory by virtue of inhibition… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Cyclo-oxygenase 2 (COX2)-selective inhibitors should reduce ulcer complications compared with non-selective non… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND The potential for cyclo-oxygenase 2 (COX2)-selective inhibitors to increase the risk for myocardial infarction is… (More)
Is this relevant?
2004
2004
OBJECTIVE To compare the incidence of gastroduodenal ulcers in patients with osteoarthritis (OA) treated with therapeutic doses… (More)
Is this relevant?
2004
2004
BACKGROUND Lumiracoxib (Prexige; Novartis Pharma AG, Basel, Switzerland) is a cyclooxygenase-2 selective inhibitor associated… (More)
Is this relevant?
2004
2004
Lumiracoxib (Prexige; 2-[(2-fluoro-6-chlorophenyl)amino]-5-methyl-benzeneacetic acid) is a novel, chemically distinct… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2004
2004
BACKGROUND Lumiracoxib is a new cyclo-oxygenase-2 (COX-2) selective inhibitor in development for the treatment of rheumatoid… (More)
Is this relevant?